srch

Breezula Phase II Trials Very Successful. In July of last year, Cassiopea stated that the interim Phase II clinical trial results for Breezula were very ...

... Cassiopea today released 6-month data from their ongoing trial of topical antiandrogen Breezula (a.k.a CB 03-01). ... Admin: Forum Administrator

Many hair loss sufferers have taken it upon themselves to acquire CB0301 and test it on themselves. There are various forum threads (such as ...

17.04.2019 · Breezula Phase 3 trials have now been delayed till 4th quarter 2020 or 1st quarter 2021. All due to COVID-19 (Coronavirus), which has hit Italy particularly hard. More information can be found in Cassiopea’s 2019 Annual Results presentation, which was released today. The Clascoterone female pattern hair loss Phase 2 trials are on track to ...

Breezula (CB-03-01) is being found to be safe and effective in clinical trials. "If approved, Breezula ... View Profile · View Forum Posts.

Category: Alopecia Pipeline, Baldness Cure, Biotechnology, Cure for Hair Loss, FUE, Gray Hair Cure, Hair Forum, Hair Growth Pipeline, Hair Growth Treatment, ...

We will try in this article to understand more about Breezula (clascosterone), ... Iscritto al forum Ieson dal 2007 – Salusmaster dal 2007 ...

04.12.2009 · Beste forum leden, Ik ben me aan het verdiepen in het verkrijgen van cb-03-01. Dit is zoals vele waarschijnlijk al weten de werkzame stof in Breezula, een haarverlies product dat rond 2022 op de markt zou moeten komen.

In realtà qualsiasi endocrinologo con un minimo di esperienza sa che deve prescrivere estradiolo in assenza di testosterone.

Welcome to Hair loss Experiences hair loss forum. Free impartial hair loss advice, hair transplant advice, hair loss medications and hair ...

24.07.2020 · Breezula (CB-03-01) is being found to be safe and effective in clinical trials. "If approved, Breezula (Clascoterone) will be the first FDA-approved topical anti-androgen for the treatment of androgenetic alopecia. Based on these great results, Cassiopea plans to proceed with 6-month Phase III trials in men in the fourth quarter of 2019, after consultation with the …

16.04.2019 · I agree that these results are bizarre, given the drop from 20.8 to 14.3 from month 6 to 12. However, compared to Finasteride at 12 months, the results indicate that Breezula is about 70% as effective (20.1 vs 14.3). I think that this is encouraging, especially when only 2 topical applications per day is 70% as effective as finasteride (which ...

21.07.2021 · I do hope Breezula will give some updates on the status of their phase 3 trials soon, things have been awfully quiet for a while now, but I assume mostly just due to the pandemic and I do believe this will most likely be available on the market to treat AA in the next 3 or so years.

Fuck it, I’m buying some Breezula (CB) Well since phase 3 trials have proven this compound to be safe enough to use in young teenager and it’s proven to lack systemic sides, I’m ordering this stuff online and using it myself until the real deal comes out. I’m only a nw1.5 but I refuse to take finasteride or minox and I refuse to wait ...

17.11.2019 · Quindi Breezula sarebbe in linea coi suoi risultati, anche se sfugge la salita e quindi la discesa dei risultati durante il primo anno di utilizzo. Ciao MA - r l i n . C. ... non farmi dire le cose da utenti sui forum o da dottori di cui non hai fiducia. Non ho mai toccato minoxidil e non penso lo tocchero' mai, ...

However, compared to Finasteride at 12 months, the results indicate that Breezula is about 70% as effective (20.1 vs 14.3). I think that this is ...

17.11.2019 · Io il CB l'ho provato 2 mesi al 7,5% (Johnny) poi 1 altro mese e mezzo col mio a percentuali del 5% e sceso al 2,5% l'ultimo mese. Ho sempre avuto avvisaglie di sides da antiandrogeno, alla percentuale del 2,5% abbastanza blandi.

Breezula et Winlevi utilisent le même principe actif, donc je pense que Winlevi peut temporairement remplacer Breezula en attendant 2022. A condition que la dose de 1% soit tout de même assez efficace pour l'alopécie évidemment, car il y a un monde entre 1% et 7%.